Investor profile
Beat Steffen
Corporate VC, Venture capital & Managing Director Novartis Venture Fund at Novartis, Member Board of Directors at UZH Life Sciences Fund
Beat Steffen is a Managing Director Novartis Venture Fund at Novartis, whose known portfolio counts 16 companies.
Is Beat Steffen a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechCell & Gene TherapyDiagnosticsDigital HealthDrug DiscoveryGenomicsImmunologyMedTechOncologyPharmaUniversity spin-offs
Contacts
Affiliated funds' portfolios
Managing Director Novartis Venture Fund at Novartis, whose known portfolio counts 16 companies
- Octave
- Vor Biopharma
- Patientory
- Orna Therapeutics
- Pliant Therapeutics
- TScan Therapeutics
- CatalYm
- Dren Bio
- Surface Oncology
- Cadent Therapeutics
- Flare Therapeutics
- Medtech Africa
- and 4 more
Member Board of Directors at UZH Life Sciences Fund, whose known portfolio counts 6 companies
- ImmunOs Therapeutics
- Cutiss
- FimmCyte
- Navignostics
- Occlufit
- metaLead Therapeutics
Investor Profile
Founders in the listed sector Healthcare, and focus areas Biotech, Cell & Gene Therapy, Diagnostics and Digital Health fall inside that listing.
Novartis appears in Growth, Seed and Series A rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Beat Steffen matches their raise.
Colleagues
Paolo Malerba
Strategy Lead
London, United Kingdom
Jose Marcilla
President Latin America and Canada (LACan) Region
United States
Marianne Uteng
Managing Director
Basel, Switzerland
Anja König
Global Head Novartis Venture Fund
Basel, Switzerland
Jason Freeman
Senior Medical Director
Washington, United States
Shejoy Varghese
Managing partner
Ernakulam, India
Marc Ceulemans
Head, Strategic Venture Capital Fund
Laax, Switzerland
Md. Sohel Rana
Managing Partner
Bangladesh
Steven Breazzano
Investor
Fairfield, United States
Lauren Silverman
Managing Director
Cambridge, United States
Stefanie D.
Portfolio Reporting Director
Zürich, Switzerland
Michio Painter
Investment Manager and Board Secretary
Zürich, Switzerland
Frequently asked questions
Who is Beat Steffen?
Beat Steffen is a corporate venture investor and venture capital investor based in Basel, Switzerland, listed as Managing Director Novartis Venture Fund at Novartis. The known portfolio of that firm counts 16 companies. That portfolio belongs to the firm, not to Beat Steffen personally.
What does Beat Steffen invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell & Gene Therapy, Diagnostics and Digital Health. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Beat Steffen invest at?
Novartis appears in Growth, Seed and Series A rounds across its known deals, and Beat Steffen is listed there as Managing Director Novartis Venture Fund. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Beat Steffen listed at?
Beat Steffen is listed as Managing Director Novartis Venture Fund at Novartis. 12 other people in the database share a firm with Beat Steffen.
How do I contact Beat Steffen?
An email address, a phone number and a LinkedIn page are on file for Beat Steffen. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal